Skip to main content
. 2020 Dec 23;14(9):2037–2046. doi: 10.1093/ckj/sfaa266

Table 1.

Baseline characteristic of patients

Age (years), mean ± SD (range) 50.6 ± 16 (26–70)
Gender (male/female), n (%) 7 (58.3)/5 (41.7)
Hypertension, n (%) 9 (91.6)
Diabetes mellitus, n (%) 8 (66.7)
Dyslipidaemia, n (%) 10 (83.3)
Diagnosis CKD, n (%)a (two cases RB)
 Obesity 7 (58.3)
 Diabetic nephropathy 4 (33.3)a
 Chronic glomerular disease 1 (8.3)a
Fatty liver, n (%) 8 (66.7)
Body weight (kg), mean ± SD (range) 116 ± 23.2 (89.7–173.5)
BMI (kg/m2), mean ± SD (range) 41.1 ± 4.4 (35.1–48.1)
Body fat (%), mean ± SD 42.5 ± 7.5
Waist circumference (cm), mean ± SD (range) 127 ± 11.4 (111–148)
Hip circumference (cm), mean ± SD (range) 128.3 ± 11.9 (105–145)
eGFR (MDRD; mL/min), mean ± SD 96.8 ± 49.8
Proteinuria (g/24 h), mean ± SD 2.6 ± 2.9
Median (IQR) 1.6 (1–2.7)
Concomitant medication, n (%)
 RAAS blocker 12 (100)
 Insulin 5 (41.7)
 Oral anti-diabetics 5 (41.7)
 Statins 7 (58.3)
 Fibrates 3 (25)
a

Patients with renal biopsy; one patient with diabetic nephropathy and the other with chronic glomerular disease.